Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Pharma-Bio Serv Inc. (PBSV) had Return on Equity of 0.79% for the most recently reported fiscal quarter, ending 2025-04-30.
| Income Statement Financials | |
$2.42M |
|
$0.10M |
|
$1.60M |
|
$0.82M |
|
$2.52M |
|
$-0.10M |
|
$0.20M |
|
$0.10M |
|
$0.10M |
|
$0.10M |
|
$0.10M |
|
$0.10M |
|
$0.10M |
|
$-0.10M |
|
$-0.04M |
|
22.93M |
|
22.94M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$13.42M |
|
$0.15M |
|
$0.49M |
|
$13.90M |
|
$1.78M |
|
-- |
|
-- |
|
$1.78M |
|
$12.12M |
|
$12.12M |
|
$12.12M |
|
22.93M |
|
| Cash Flow Statement Financials | |
$-0.73M |
|
$-2.24M |
|
$-1.74M |
|
$6.77M |
|
$2.09M |
|
$-4.67M |
|
$0.02M |
|
$-1.72M |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
33.87% |
|
-4.07% |
|
-4.07% |
|
-- |
|
4.17% |
|
3.94% |
|
$-0.74M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
-- |
|
0.90 |
|
99.94 |
|
|
Return on Equity |
0.79% |
0.79% |
|
0.69% |
|
0.79% |
|
$0.53 |
|
$-0.03 |
|
$-0.03 |
|